SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-036848
Filing Date
2024-08-12
Accepted
2024-08-12 16:24:10
Documents
19
Period of Report
2024-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20033947_8k.htm   iXBRL 8-K 45810
2 EXHIBIT 4.1 ef20033947_ex4-1.htm EX-4.1 131048
3 EXHIBIT 10.1 ef20033947_ex10-1.htm EX-10.1 263498
4 EXHIBIT 10.2 ef20033947_ex10-2.htm EX-10.2 45750
5 EXHIBIT 10.3 ef20033947_ex10-3.htm EX-10.3 22057
6 EXHIBIT 10.4 ef20033947_ex10-4.htm EX-10.4 64740
7 EXHIBIT 99.1 ef20033947_ex99-1.htm EX-99.1 11720
  Complete submission text file 0001140361-24-036848.txt   856965

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA eltx-20240812.xsd EX-101.SCH 3859
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltx-20240812_lab.xml EX-101.LAB 22690
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltx-20240812_pre.xml EX-101.PRE 16548
21 EXTRACTED XBRL INSTANCE DOCUMENT ef20033947_8k_htm.xml XML 4225
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 241197120
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)